Cellestia - About Us

Cellestia is giving hope to cancer patients who have no other treatment or therapy options. Our drug discovery platform, built on a unique mode of action and together with companion diagnostics, is a first-in-class solution for orphan cancers such as cancer of the salivary gland and childhood Leukaemia. At the same time, we are continuing to expand our portfolio through targeting large cancer indications such as breast and colorectal cancers.

Cellestia is a privately-owned clinical-stage biopharma company led by an experienced team of scientists, drug developers and business professionals. We are providing hope for thousands of cancer patients and their families.

WE ASPIRE TO

Cure cancer

We aspire to reach true breakthroughs in cancer treatments and therapies that will ultimately lead to a cure for cancers previously incurable.

WE ARE RESOLUTE IN OUR

Dedication to patients

There is no compromise to our dedication to the patients we serve. We put their needs first and are resolute in our search for groundbreaking novel therapies.

WE EXTEND AND IMPROVE

Quality of life

We are developing safe and therapeutic solutions to extend and improve the quality of life for patients who currently have no other treatment options.

WE ARE RELENTLESS IN OUR PURSUIT OF

Pioneering science

While others may use words like innovative, unique and novel in an attempt to differentiate themselves, CB-103’s mode of action is a true scientific disruption in the treatment of NOTCH-driven cancers.

WE DO WHATEVER IT TAKEs TO

Adapt to the unknown and shape
the future

We hold each other responsible and accountable to the vision and goals we share as we carve our own path forward.

We are all in

We understand what is at stake for patients and their families and as a result we are willing to put our reputations, time with our loved ones and our own resources on the line. We are all in.